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Synapses which employ biogenic amines as neuro- 
transmitters arc believed to contain both pm- and 
postsynaptic receptors. The classical postsynaptic 
receptors recognize the transmitter and mediate the 
response of the postsynaptic cell whereas the pre- 
synaptic receptors are presumed to control and 
modulate the extent of neurosecretion per sti~~lulus 
(reviewed [i] ). It has also been suggested that some 
cholinergic synapses contain pmsynaptic muscarinic 
receptors which regulate the extent of Ach release by 
feedback inhibition [2%4] . 
It is well established that the lorpedo electric 
organ is innervated by chol~ner~ic synapses whose 
postsynaptic receptors are nicotinic cholinergic [5,6]. 
The observation that muscarinic ligands bind to the 
homogenate of the electric organ of ~~~~~~ [7,8] 1) 
suggests that this tissue contains musearinic receptors. 
Hence, we have decided to investigate and characterize 
the Tov~edo electric organ ~~~scarinic receptors, and 
to determine their subcellular localization. 
The electric organs were ~ol~ogenized and 
fractionated as in [g,lO] . The homogenized material 
(H> was cent~ifMged for IQ min at 1000 X g. The 
resulting supernat~t (S1) was subjected to further 
centrifugation at 17 500 X g for 1 h. The Pz pellet 
was resuspended and loaded onto the sucrose density 
gradient which was composed of 6 layers (al--a&) 
all of which c~~t~~~d 1mM EGTA and one of the 
following concentrations of sucrose: 0,0.15,0.3, 
0.55,0.8, 1.6 M. Layers ai-a4 also co~taliled glycine 
so that their osmolarity was equal to that of the 
ho~~o~e~~ization buffer. After centrifugatian in a 
SW40 rotor spun at 110 000 X g for 1 h, the material 
was carefully collected starting at the upper interfaces. 
In this study, fractions a2 and a3, which are the most 
enriched in synapt~s#mes [IO] were pooled together. 
Similarly fractions as and a6 which contain most of 
the ~-b~ngarotoxin (e+Bgt) binding were also combined. 
N- ~3~]Methyl-4-pi~eridyl benzilate (4-N [aH]MPB) 
and 3- f3H] qu~nuclidi~~l benziIate (3-E3H] QNB) binding 
were performed as in [,I l] . The nicotinic acetylcholine 
receptor was assayed with 12sI-labelle~l o-Bgt using 
the method in [ 12f * 
3. Results and discussion 
The electric organ of Torpedo ~~~1~~~~ is amply 
endowed with the nicotinic cholinergic receptor 
(10.6 nmollg electropfax tissue). As shown in table 1) 
the electric organ hor~ogenate also spec~~ca~y binds 
the muscarinic antagonists 3-f3H]QNB and 4-Ni3H]- 
MPB, Within experiments error these muscarinic 
ligands bind to the same number of sites, which, in 
the homogenate, are at -400 fmol/g elcctroplax 
tissue, Thus, the homogenate contains -1 muscarinic 
antagonist site/25 000 cr.Bgt binding sites. These 
findings are similar to those recently reported for 
3- [%]QNB binding to the electric organ of ~u~~~~~ 
~~r~~~~~ta [S] . Following differential centrifugation, 
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Volume 95, number 2 FEBS LETTERS November 2978 
most of the tu-Bgt, 3-[‘H]QNB and 4-N~~H]MPB 
binding capacities are found in the Pz pehct (table I ). 
Figure 1 depicts the distribution of ligand binding 
sites in the density czntrifugation fractions. Most of 
the e&&t binding is found in fractions a5 + a6, 
whereas fractions a2 + as contain only -7% of the 
parent fraction tp2) binding. By contrast, fraction 
a2 + a3 contain about 40% of the 3-f3H]QNB and 
4-N[3H]MPB binding. As expected, both ligands have 
identical bindmg capacities [ 131 . The ratio of mus- 
carinic to nicotinic binding in fraction a2 + a3 is 
about 5fofd larger than in the ~~omogenate ( able 1). 
The high specific binding (-160 fmol/mg protein) 
of muscarinic antagonists to fraction a2 + a3 suggests 
that this fraction is enriched in muscarinic receptors. 
This assertion was fortified by the following observa- 
tions: 3-t3H]QNB binds to the synaptosomal fraction 
with fird 0.3 * 0.1 nM and 4-N~~~~J~~P~ with Kd 
I .O f 0.2 nM ffig.2). Comp~tit~on binding experiments 
of atropine/3- [“HI QNB and atropine/4-N F3H]MPB 
yielded in both cases K, 3.3 f 0.2 nM. In all cases a 
Hill coefficient of 1 was obtained. Competition 
experiments using the agonist oxotremorine and 
.3- [ ‘H] QNB and 4-N t3H] MPB yielded I,, values of 
at a2ba3 a4 
I ::: --- .., .  ___ iii--I:: --- i i i  --- _._ ___ 
a5+a6 
Q-I t_igand t nw 
f 
Fig.1. Distribution of ‘Z I-labelled ~Bgt, 3-i ‘H]QNB and 
4-N[3H]MPB binding in the sucrose density gradientfrac~ions. 
Absolute vafues for the parent fraction (plf ioaded onto the 
gradient were as follows: 42.9 mg protein; 33 nmoi o-Bgt 
binding sites; 1.2 pm01 of 3-[ ‘H]QNB and of 4-N13H]MPB 
binding sites. Recoveries were as follows; protein 102 * 10%; 
‘251-hrbelled ol-Bgt binding, 105 i 10%; 3-[ 3H]QNB 88 i- 15%; 
4-N] ?X] MPB 102 + 15%. Data presented are the mean of 
4 separate experiments. Vertical bars represent SD. 
W Lisand bOunti ffmot/mg protein) 
Fig.2. Binding of4-Nt3H]MPB and 3-[3H]QNB to fraction a, + a$. (A) Samples at 0.2-0.4 ml [containing 0.3-0.6 mg protein) 
were incubated for 60 mm with varying concentrations of 3-[3H]QNB and for 30 min with varying concentrations of4-N[3H]MPB. 
Experiments were performed at 25°C in 2 mt modified Krebs solution (pH 7.4). (* - 8) Specific and (A - A) non-specific binding 
<in the presence of 25 PM atropine) of 3-]‘H]QNB, and fo - o) specific and (A - a) non-specific binding of 4-N[ 3H]MPB. (B) Same 
data replofted according to Scatchard [ 141 for 3-t3H]QNB (o-o) and for 4-NE3H]MPB (o-o) binding. 
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0.085-0.1 PM and 0.1-0.2 PM, respectively and a 
Hill coefficient of -0.6. The affinity of agonists is 
presented in Iso rather than in K, values since, due to 
the low Hill coefficient, the assignment of K, values 
depends on their mode of binding. The present 
findings arc similar to those obtained with I~lalnrnaIian 
muscarinic receptors [I 1,13,15-191 _ The nicotinic 
ligands d-tubocurarine (Glow5 M) and cu-Bgt 
(<lo-’ M) had no effect on 3-C3H]QNB and 
4-N [3H]MPB binding. Thus we may conclude that 
the synaptosomal fraction a2 t a3 [lo], is enriched 
in muscar~r~ic receptors. The muscarinic and nicotinic 
receptors found in fraction a5 + a6 probably arise 
from postsynaptic and presynaptic membranes which 
under our homogenization conditions did not detach 
from the larger postsynaptic electroplaque membrane. 
A muscarinic binding capacity of about 80 fmol/mg 
protein in purified postsynaptic l~~ernbr~es was found 
[S] which is about Z-fold lower than that presently 
obtained with isolated intact synaptosomes (table 1). 
Synaptosomal membranes prepared by osmotic lysis 
and recentrifugation of a2 t a3, contain even higher 
specific binding, i.e., 350 fmoi/mg protein. 
In conclusion. the findings presented demo~~strate 
that the Torpedo electric organ contains muscarinic 
receptors which can be separated from the classical 
nicotinic receptor. The high enrichment of the 
muscarinic receptors in the synaptosomal fraction, 
which contains only traces of the postsynaptic mem- 
branes, implies that in the Torpedo the i?luscarinic 
receptors may be located in the presynaptic mem- 
brane. As yet the physiological role of the muscarinic 
receptor in Torpedo is not known. Preliminary results 
in our laboratory indicate that muscarinic Iigands 
interfere with Ca”induced synaptosomal acetyl- 
choline secretion, thus suggesting that these receptors 
may function in the control and modulation of 
acetylchoIine release. 
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